US FDA approved drugs from 2015–June 2020: a perspective

P Bhutani, G Joshi, N Raja, N Bachhav… - Journal of Medicinal …, 2021 - ACS Publications
In the present work, we report compilation and analysis of 245 drugs, including small and
macromolecules approved by the US FDA from 2015 until June 2020. Nearly 29% of the …

Mucosal immune responses to infection and vaccination in the respiratory tract

RC Mettelman, EK Allen, PG Thomas - Immunity, 2022 - cell.com
The lungs are constantly exposed to inhaled debris, allergens, pollutants, commensal or
pathogenic microorganisms, and respiratory viruses. As a result, innate and adaptive …

Genomic diversity of severe acute respiratory syndrome–coronavirus 2 in patients with coronavirus disease 2019

Z Shen, Y Xiao, L Kang, W Ma, L Shi… - Clinical infectious …, 2020 - academic.oup.com
Background A novel coronavirus (CoV), severe acute respiratory syndrome (SARS)–CoV-2,
has infected> 75 000 individuals and spread to> 20 countries. It is still unclear how fast the …

Metagenomic analysis reveals oropharyngeal microbiota alterations in patients with COVID-19

S Ma, F Zhang, F Zhou, H Li, W Ge, R Gan… - … and Targeted Therapy, 2021 - nature.com
COVID-19 remains a serious emerging global health problem, and little is known about the
role of oropharynx commensal microbes in infection susceptibility and severity. Here, we …

Alterations in the respiratory tract microbiome in COVID-19: current observations and potential significance

C Merenstein, FD Bushman, RG Collman - Microbiome, 2022 - Springer
SARS-CoV-2 infection causes COVID-19 disease, which can result in consequences
ranging from undetectable to fatal, focusing attention on the modulators of outcomes. The …

Oral microbiome alterations and SARS-CoV-2 saliva viral load in patients with COVID-19

EH Miller, MK Annavajhala, AM Chong… - Microbiology …, 2021 - Am Soc Microbiol
Bacterial-viral interactions in saliva have been associated with morbidity and mortality for
respiratory viruses such as influenza and SARS-CoV. However, such transkingdom …

Microbiome disturbance and resilience dynamics of the upper respiratory tract during influenza A virus infection

D Kaul, R Rathnasinghe, M Ferres, GS Tan… - Nature …, 2020 - nature.com
Infection with influenza can be aggravated by bacterial co-infections, which often results in
disease exacerbation. The effects of influenza infection on the upper respiratory tract (URT) …

Role of microbiota in viral infections and pathological progression

T Mizutani, A Ishizaka, M Koga, T Tsutsumi… - Viruses, 2022 - mdpi.com
Viral infections are influenced by various microorganisms in the environment surrounding
the target tissue, and the correlation between the type and balance of commensal microbiota …

Intranasal Bifidobacterium longum protects against viral-induced lung inflammation and injury in a murine model of lethal influenza infection

D Groeger, E Schiavi, R Grant, M Kurnik-Łucka… - …, 2020 - thelancet.com
Background Prophylactic strategies are urgently needed for prevention of severe
inflammatory responses to respiratory viral infections. Bacterial-host interactions may modify …

Characterization of the human oropharyngeal microbiomes in SARS‐CoV‐2 infection and recovery patients

M Gao, H Wang, H Luo, Y Sun, L Wang… - Advanced …, 2021 - Wiley Online Library
Respiratory tract microbiome is closely related to respiratory tract infections, while
characterization of oropharyngeal microbiome in recovered coronavirus disease 2019 …